219 results on '"de Vos, Dick"'
Search Results
2. Synthesis and structures of polynuclear organotin(IV) complexes of a polyaromatic carboxylate ligand and cytotoxic evaluation in tumor cell lines
3. Synthesis and structures of polynuclear organotin(IV) complexes of a polyaromatic carboxylate ligand and cytotoxic evaluation in tumor cell lines
4. Synthesis, structural characterization and in vitro biological screening of some homoleptic copper(II) complexes with substituted guanidines
5. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[( E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: Structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines
6. Molecular basis of the interaction of novel tributyltin(IV) 2/4-[( E)-2-(aryl)-1-diazenyl]benzoates endowed with an improved cytotoxic profile: Synthesis, structure, biological efficacy and QSAR studies
7. Dibutyltin(IV) complexes containing arylazobenzoate ligands: chemistry, in vitro cytotoxic effects on human tumor cell lines and mode of interaction with some enzymes
8. Synthesis, characterization, in vitro cytotoxicity and anti-inflammatory activity of palladium(II) complexes with tertiary phosphines and heterocyclic thiolates: Crystal structure of [PdC 28H 19N 8PS 2]
9. Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes
10. In vitro cytotoxic evaluation of novel dichlorodiorgano[N-(2-pyridylmethylene)arylamine]tin(IV) derivatives in human tumor cell lines
11. Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies
12. Cytotoxicity, qualitative structure–activity relationship (QSAR), and anti-tumor activity of bismuth dithiocarbamate complexes
13. Self-assembly of extended Schiff base amino acetate skeletons, 2-{[(2 Z)-(3-hydroxy-1-methyl-2-butenylidene)]amino}phenylpropionate and 2-{[( E)-1-(2-hydroxyaryl)alkylidene]amino}phenylpropionate skeletons incorporating organotin(IV) moieties: Synthesis, spectroscopic characterization, crystal structures, and in vitro cytotoxic activity
14. Synthesis, characterization, antibacterial and cytotoxic activity of new palladium(II) complexes with dithiocarbamate ligands: X-ray structure of bis(dibenzyl-1-S:S′-dithiocarbamato)Pd(II)
15. Structure-dependent in vitro cytotoxicity of the isomeric complexes [Ru(L)2Cl2] (L=o-tolylazopyridine and 4-methyl-2-phenylazopyridine) in comparison to [Ru(azpy)2Cl2]
16. Synthesis and characterization of bis[dicarboxylatotetraorganodistannoxane] units involving 5-[( E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoic acids: An investigation of structures by X-ray diffraction, NMR, electrospray ionisation MS and assessment of in vitro cytotoxicity
17. Diphenyltin(IV) complexes of the 5-[( E)-2-(aryl)-1-diazenyl]quinolin-8-olates: Synthesis and multinuclear NMR, 119Sn Mössbauer, electrospray ionization MS, X-ray characterization and assessment of in vitro cytotoxicity
18. Synthesis, characterization, cytotoxic activity and crystal structures of tri- and di-organotin(IV) complexes constructed from the β-{[( E)-1-(2-hydroxyaryl)alkylidene]amino}propionate and β-{[(2 Z)-(3-hydroxy-1-methyl-2-butenylidene)]amino}propionate skeletons
19. In vitro cytotoxic evaluation of novel dichlorodiorgano[N-(2-pyridylmethylene)arylamine]tin(IV) derivatives in human tumor cell lines
20. Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes
21. Tridemethylisovelleral, a potent cytotoxic agent
22. Decitabine: a historical review of the development of an epigenetic drug
23. Dibutyltin(IV) complexes of the 5-[( E)-2-(Aryl)-1-diazenyl]-2-hydroxybenzoic acid ligand: an investigation of structures by X-ray diffraction, solution and solid state tin NMR, electrospray ionisation MS and assessment of in vitro cytotoxicity
24. Serum and urine levels of tamoxifen and its metabolites in patients with advanced breast cancer after a loading dose and at steady-state levels
25. Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer
26. Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies
27. Synthesis, characterization and in vitro antitumor activity of di- and triorganotin derivatives of polyoxa- and biologically relevant carboxylic acids
28. Dibutyltin perfluoroalkanecarboxylates: synthesis, NMR characterization and in vitro antitumour activity
29. Synthesis, characterization, and in vitro cytotoxicity of some gold(I) and trans platinum(II) thionate complexes containing water-soluble PTA and DAPTA ligands: X-ray crystal structures of [Au(S[C.sub.4][H.sub.3][N.sub.2])(PTA)], trans-[Pt[(S[C.sub.4][H.sub.3][N.sub.2]).sub.2][(PTA).sub.2]], trans-[Pt[(S[C.sub.5][H.sub.4]N).sub.2][(PTA).sub.2]], and trans-[Pt[(S[C.sub.5][H.sub.4]N).sub.2][(DAPTA).sub.2]]
30. Decitabine: a historical review of the development of an epigenetic drug
31. Giving Kids Hope.
32. Synthesis and in vitro antitumour activity of organotin dervatives of carboranes
33. Organotin(IV) derivatives of dipeptides : synthesis, characterization and in vitro antitumour activity
34. Synthesis, Characterization, X-ray Crystal Structure and in vitro antitumour activity of sodium bis 2-(3',6',9'-Trioxadecyl)- 1,2- Dicarba-closo-dodecaborane-1-carboxylato) triphenylstannate
35. Dibutyltin (IV) complexes of the 5-[(E)-2-(Aryl)-1-diazenyl]-2-hydroxybenzoic acid ligand: an investigation of structures by X-ray diffraction, solution and solid state tin NMR, electrospray ionisation MS and assessment of in vitro cytotoxi city
36. Synthesis, characterization X-ray crystal structure and in vitro antitumour activity of bis(1,2-dicarba-closo-dodecaborane-9-carboxylato)di-n-butyltin
37. Novel tin carborane carboxylates. Synthesis, characterization and in vitro antitumour activity
38. Synthesis, Characterization and In Vitro Antitumour Activity of Di- and Triorganotin Polyoxacarboxylates
39. Synthesis, Characterization and in vitro Antitumour Activity of Di- and Triorganotin Derivatives of Polyoxacarboxylic acids
40. Di-n-butyltin derivatives of bis(carboxymethyl)benzylamines: synthesis, NMR and X-ray structure characterization and in vitro antitumour properties
41. Synthesis, characterization and antitumour activity of some butyltin(IV) cysteaminatesand N,N-dimethylcysteanates
42. Tin polyoxaalkanecarboxylates and compositions containing them
43. Organotin(IV) Derivatives of 3,4-(Methylene-Dioxy)Phenylacetic Acid: Synthesis, Spectroscopic Characterization and In Vitro Antitumour Activity
44. Di- and Tri-organotin Derivatives of 3S,4S-3[(R)-1-(tert-butyl- dimethylsilyloxy)ethyl]-4-[(R)-1-carboxyethyl]-2-azetidinone: Synthesis, Characterization and in vitro Antitumour Activity
45. Organotin compounds and compositions containing these compounds
46. Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
47. Synthesis, Charaterization and Antitumour Activity of Di-n-Butyl Salicyloxamate
48. Synthesis, Characterization and Antitumour Activity of Di-n-Butyl- and Dimethyltin D+ - Camphorates
49. Aromatic fluorine-containing organotin compounds and anti-tumour composition
50. Dibutyltin bis(dihydroxybenzoates) and compositions containing these compounds
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.